Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sarah Klinnert
Observed name:
Klinnert, Sarah
Institutions:
University of Zurich,
University Hospital Zurich,
Life Science Zurich
Observed institutions:
The University of Texas at San Antonio Health Science Center,
University of Zurich,
University Hospital Zurich,
Life Science Zurich
ORCID:
0000-0002-1604-7917
Observed ORCID:
0000-0002-1604-7917
OpenAlex ID:
A5014071106
The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation
2020
·
Adam Kosti
, Patricia Rosa de Araujo
, et al.
·
Genome biology
·
121
PDF
Targeted shock-and-kill HIV-1 gene therapy approach combining CRISPR activation, suicide gene tBid and retargeted adenovirus delivery
2023
·
Sarah Klinnert
, Corinne D. Schenkel
, et al.
·
Gene Therapy
·
33
PDF
Systematic HIV-1 promoter targeting with CRISPR/dCas9-VPR reveals optimal region for activation of the latent provirus
2022
·
Sarah Klinnert
, Alex Chemnitzer
, et al.
·
Journal of General Virology
·
7
Targeting HIV-1 with CRISPR/Cas9 delivered by retargeted adenoviruses effectively suppresses viral replication
2023
·
Sarah Klinnert
, Patrick C. Freitag
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Show more works
View as search
Works count:
23
Citation count:
161
H-index:
3
I10-index:
2
Year
Topic
Type